Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ProNova Preps Its Next-Gen SC360 For Smaller, Cheaper Era Of Proton Therapy

This article was originally published in The Gray Sheet

Executive Summary

The system, which developers hope to launch in the U.S. in 2015 following completion of a 510(k) submission to FDA, will cost about $50 million for a two-room configuration, and the gantry will weigh 15 tons, well under the typical 110-220-ton weight of most systems, according to ProNova.


Related Content

New Product Briefs: Hearing Device; Volcano’s iFR Modality; St. Jude Pain Device
ASTRO Meeting In Brief
Prostate Cancer Radiation Comparisons Support IMRT, Question Proton Therapy
Siemens’ Integration Of PET Imaging Partner CTI Follows Expanded Coverage


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts